세계 주사형 약물전달 기기 시장 규모는 2024년 2,165억 달러에서 예측 기간 동안 CAGR 7.9%로 추이하고, 2029년에는 3,172억 달러에 이를 것으로 예측됩니다.
북미 시장은 2024년 773억 달러에서 예측 기간 동안 CAGR 6.2%로 추이하고, 2029년에는 1,044억 달러에 달할 것으로 예측되고 있습니다. 아시아태평양 시장은 2024년 567억 달러에 이르고, CAGR 9.5%로 추이하고 2029년에는 891억 달러에 이를 것으로 예측됩니다.
본 보고서에서는 세계의 주사형 약물전달 기기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 법규제 환경, 신기술 및 기술 개발의 동향, 시장 규모 추이와 예측, 각종 구분· 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
개요
PESTEL 분석
Porter's Five Forces 분석
공급망 분석
제3장 시장 역학
개요
시장 성장 촉진요인
만성 질환 증가와 인구의 고령화
기술의 진보
환자의 자가 투여 선호도
생물 제제의 진보
시장 성장 억제요인
안전상의 우려
시장 기회
신흥 시장
시장의 과제
환자의 컴플라이언스와 수용
제4장 규제 상황
개요
미국
EU
일본
제5장 신기술과 개발
신흥기술
3D 프린팅
나노입자 전달 시스템
생분해성 및 지속 방출 시스템
특허 분석
연별 특허
출원인별 특허
소유자별 특허
발명자별 특허
관할별 특허
임상시험 분석
임상시험 분석 : 연구 유형별
임상시험 분석 : 상태별
임상시험 분석 : 위상별
제6장 시장 세분화 분석
부문별 내역
주사형 약물전달 기기 세계 시장
시장 분석 : 제품별
기존 주사기
첨단 주사기기
시장 분석 : 이용 유형별
일회용 주사기
재사용 가능 주사기
시장 분석 : 투여 경로별
피하
근육내
정맥내
피내
시장 분석 : 치료 용도별
당뇨병
종양
자가면역질환
기타
시장 분석 : 최종 사용자별
병원 및 진료소
재택 케어
기타
지리적 내역
시장 분석 : 지역별
북미
유럽
아시아태평양
기타 지역
제7장 지속가능성: 주사형 약물전달 기기 산업에서 ESG의 관점
개요
ESG 데이터 이해
환경 성능
사회적 성능
거버넌스 퍼포먼스
BCC에 의한 총론
제8장 경쟁 정보
개요
주사형 약물전달 기기 제조업체의 전략
유통 네트워크
제9장 부록
조사 방법
기업 프로파일
AMGEN INC.
ASTRAZENECA
BD
BAXTER
B. BRAUN SE
F. HOFFMANN-LA ROCHE LTD.
GERRESHEIMER AG
LILLY
MERCK & CO. INC.
MEDTRONIC
PFIZER INC.
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TERUMO CORP.
YPSOMED
약어
출처
JHS
영문 목차
영문목차
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
The North American market for injectable drug delivery device is estimated to increase from $77.3 billion in 2024 to reach $104.4 billion by 2029, at a CAGR of 6.2% from 2024 through 2029.
The Asia-Pacific market for injectable drug delivery device is estimated to increase from $56.7 billion in 2024 to reach $89.1 billion by 2029, at a CAGR of 9.5% from 2024 through 2029.
Report Scope:
This report covers the global market for injectable Drug Delivery Device. It provides market projections for 2029 and analyzes the injectable Drug Delivery Device market along the following parameters: product, usage type, route of administration, therapeutic application and end users. Based on product, the injectable Drug Delivery Device market is segmented into conventional devices and advanced injectable devices. Based on usage type, the market is segmented into disposable injectors and reusable injectors. Based on the route of administration, it is segmented into subcutaneous, intramuscular, intravenous and intradermal. Based on therapeutic application, the market is segmented into diabetes, oncology, autoimmune diseases and others. Based on end user, it is segmented into hospitals and clinics, home care settings and others. The report includes a detailed competitive landscape that covers major players, market share and recent strategic developments.
Additionally, the report breaks down market trends and growth prospects across different regions. It includes market forecasts, consumer insights and a thorough supply chain analysis. By addressing distribution channels, key suppliers and other such factors, the report aims to provide a comprehensive view of the market's current state and future potential as this can help stakeholders make informed decisions and identify strategic opportunities in the injectable drug delivery device industry.
Report Includes:
46 data tables and 62 additional tables
Analyses of trends in the global market for injectable drug delivery devices, with market revenue data from 2021-2023, estimates for 2024 and projected CAGRs through 2029
Estimates of the market size and revenue growth prospects, along with a market share analysis by product, therapeutic area (application), route of administration, end user and region
Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
A Porter's Five Forces model, and global supply chain and PESTLE analyses
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
A look at the pipeline drugs, clinical trial applications and potential markets for future developments
Analysis of the competitive landscape, including companies' market shares, strategic alliances, M&A activities, and a venture funding outlook
Company profiles of major players within the industry, including BD, Sanofi, Ypsomed, Lilly, Gerresheimer AG, Medtronic, Pfizer Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
PESTEL Analysis
Porter's Five Forces Analysis
Supply Chain Analysis
Raw Materials Sourcing
Manufacturing
Packaging and Labeling
Distribution and Logistics
Marketing, Sales, and End User
Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing Prevalence of Chronic Diseases and Aging Population
Technological Advances
Patient Preference for Self-Administration
Advances in Biologics
Market Restraints
Safety Concerns
Market Opportunities
Emerging Markets
Market Challenges
Patient Compliance and Acceptance
Chapter 4 Regulatory Landscape
Overview
U.S.
EU
Japan
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
3D Printing
Nanoparticle Delivery Systems
Biodegradable and Sustained Release Systems
Patent Analysis
Patents by Year
Patents by Applicant
Patents by Owner
Patents by Inventor
Patents by Jurisdiction
Clinical Trials Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Chapter 6 Market Segmentation Analysis
Segmental Breakdown
Global Market for Injectable Drug Delivery Device
Market Analysis by Product
Conventional Injectable Devices
Advanced Injectable Devices
Market Breakdown by Usage Type
Disposable Injectors
Reusable Injectors
Market Breakdown by Route of Administration
Subcutaneous
Intramuscular
Intravenous
Intradermal
Market Breakdown by Therapeutic Application
Diabetes
Oncology
Autoimmune Diseases
Other Applications
Market Breakdown by End User
Hospital and Clinics
Homecare Settings
Others
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Sustainability: An ESG Perspective in the Injectable Drug Delivery Device Industry
Overview
Understanding the ESG Data
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 8 Competitive Intelligence
Overview
Strategies for Injectable Drug Delivery Device Manufacturers
